← All Posts
HAR
Harmony Biosciences Holdings, Inc.
May 15, 2026
•
Author: Phil Ratcliff
| Item |
Proposal |
Vote |
| 1 |
The election of four Class III directors, to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. |
|
| 1.01 |
Geno J. Germano |
✓ For(7.061)
|
| 1.02 |
Troy Ignelzi |
✓ For(7.061)
|
| 1.03 |
Ron Philip |
✓ For(7.061)
|
| 1.04 |
Andreas Wicki, Ph.D. |
✓ For(7.061)
|
| 2 |
Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. |
✓ For(7.061)
|
| 3 |
Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC’s compensation disclosure rules. |
✓ For(7.061)
|
This article was written for information purposes only and its content should not be
construed by any consumer and/or prospective client as rebel Financial's solicitation
to affect, or attempt to affect transactions in securities, or the rendering of
personalized investment advice for compensation. No client or prospective client should
assume that any such discussion serves as the receipt of, or a substitute for,
personalized advice from rebel Financial, or from any other investment professional.
See our disclosures page for more information.
rebel Financial